Infraredx: Infraredx, a Nipro Company, Announces Enrollment of First Patient in EXPANSE PTCA Study

(marketscreener.com) The objective of this study is to evaluate safety and effectiveness of the Lacrosse NSE ALPHA coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.https://www.marketscreener.com/news/latest/Infraredx-a-Nipro-Company-Announces-Enrollment-of-First-Patient-in-EXPANSE-PTCA-Study--37396938/?utm_medium=RSS&utm_content=20211222